Chronic News and Research

RSS

Aldosterone antagonist therapy can be adopted for treating heart failure

Less than one-third of patients hospitalized for heart failure and participating in a quality improvement registry received a guideline-recommended treatment of heart failure, aldosterone antagonist therapy, according to a study in the October 21 issue of JAMA.

26 Oct 2009

Inhaling carbon nanotubes can affect outer lining of the lungs

Carbon nanotubes are being considered for use in everything from sports equipment to medical applications, but a great deal remains unknown about whether these materials cause respiratory or other health problems.

26 Oct 2009

APC enzyme may be effective for treating amyotrophic lateral sclerosis

A chemical cousin of a drug currently used to treat sepsis dramatically slows the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, in mice. The results offer a bit of good news in efforts to develop a therapy to stop or slow the progression of a disease that generally kills its victims within just a few years.

26 Oct 2009

DaVita to demonstrate clinical outcomes, patient care and nutrition through 43 abstracts

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research®, today announced that company representatives will deliver 43 abstracts—40 posters and three oral presentations—at this year’s American Society of Nephrology’s (ASN) Renal Week to be held in San Diego, Calif., from Oct. 27 – Nov. 1, 2009.

24 Oct 2009

ULURU presents clinical posters; highlights efficacy of Altrazeal dressing for wound care

ULURU Inc. (NYSE Alternext: ULU) today announced that Gregory Bohn, M.D., FACS, Medical Director, Trinity Wound Care and Hyperbaric Medicine, Bettendorf, Iowa, has presented nine clinical posters at the 24th Annual "Clinical Symposium on Advances in Skin and Wound Care" being held in San Antonio, Texas.

24 Oct 2009

Doctoral candidate sheds new light on the biology of Leishmania parasites

Professor Albert Descoteaux's team at Centre INRS - Institut Armand-Frappier has gained a better understanding of how the Leishmania donovani parasite manages to outsmart the human immune system and proliferate with impunity, causing visceral leishmaniasis, a chronic infection that is potentially fatal if left untreated.

24 Oct 2009

Hypothalamic dysfunction can cause Chronic Fatigue Syndrome

Dr. Oz's guest Jacob Teitelbaum, MD, best-selling author of From Fatigued to Fantastic! (Avery Penguin Group) and Pain Free 1-2-3 (McGraw-Hill), suffered from CFS when he was in medical school and had to drop out for a year to recover.

24 Oct 2009

Report on health insurance reform to support women with breast cancer

As Americans mark breast cancer awareness month, Secretary of Health and Human Services Kathleen Sebelius today released a new report, Health Insurance Reform and Breast Cancer: Making the Health Care System Work for Women.

24 Oct 2009

Antidepressants are not effective for many people

More than half the people who take antidepressants for depression never get relief.

24 Oct 2009

PAF board member meets First Lady to dicuss denial of health insurance due to pre-existing conditions

The Patient Advocate Foundation (PAF) -- a national non-profit organization providing patient services to tens of thousands of patients every year who are unable to obtain access to care because of financial or insurance denials -- is pleased to announce that PAF Executive Board Member Venus Gines, founder and CEO of Dia de la Mujer Latina(TM) Inc (Day of the Latin American Woman), provided first-hand testimony today to First Lady Michelle Obama regarding her own and other patients' experiences in being denied health insurance due to pre-existing conditions, and the need to protect patients against such discrimination under healthcare reform.

24 Oct 2009

AGH Researchers to study the impact of biofilm infections on the success of orthopaedic procedures

Researchers from Allegheny General Hospital's (AGH) Department of Orthopaedic Surgery and Center for Genomic Sciences have launched dual groundbreaking studies that may help determine the cause of two common, hard-to-treat problems experienced by patients who undergo orthopedic surgery: a joint replacement that becomes infected and a bone fracture that will not heal properly.

24 Oct 2009

Orthopedic surgeon to present latest findings on stem cells and plasma rich platelet therapy

Joseph Purita M.D., a well known Orthopedic Surgeon from Florida has announced that plans are being made with the Orthopedic Academies in Sao Paulo Brazil to present his latest findings on the use of stem cells and plasma rich platelet therapy in the treatment of certain bone and joint problems.

24 Oct 2009

Neuros Medical announces $1.8 million series A round of investment

Neuros Medical, Inc., a medical device company developing innovative neurostimulation technology for the treatment of chronic pain, announced today a $1.8 million series A round of investment, led by the North Coast Angel Fund (NCAF), which was joined in the investment by Glengary LLC, Ohio Tech Angel Fund, Queen City Angels First Fund III, and individual investors. This round follows the initial investment made earlier in the year from JumpStart Ventures and Case Technology Ventures.

24 Oct 2009

Learn to recognise stroke symptoms and take action: World Stroke Organization

The theme of this year's World Stroke Day on 29th October is "What can I do?". As the World Stroke Organization says, everyone can do something: learn to recognise symptoms and take action, learn to recognise the risk factors and take action.

24 Oct 2009

Ontario doctors urge employers not to ask sick note from a physician for employees taking leave this flu season

In advance of what is shaping up to be an unprecedented flu season, Ontario's doctors are encouraging employers to reconsider asking their employees for a sick note from a physician because of an absence from work.

24 Oct 2009

University neurologists launch multiple sclerosis research study

Neurologists at the University at Buffalo are beginning a research study that could overturn the prevailing wisdom on the cause of multiple sclerosis (MS).

24 Oct 2009

PPA reaches historic milestone; helps the six millionth person

After visiting more than 3,000 cities in all 50 states, the Partnership for Prescription Assistance (PPA) has reached a historic milestone today by helping the six millionth person at an event in Harrisburg, Pennsylvania.

24 Oct 2009

Wellness and prevention mostly absent in health reform bills

"Despite Americans' poor lifestyle choices and the chronic problems they spawn, the health-care reform proposals being considered in Congress contain relatively little to promote wellness," The Tennessean reports.

24 Oct 2009

Cohen Independent Research Group publishes a report profiling Nutra Pharma

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that Cohen Independent Research Group has published a report profiling Nutra Pharma Corporation.

24 Oct 2009

One in 10 adolescents exhibit chronic behavior problems

Ten percent of young adolescent boys -- or one in 10 -- exhibit a symptom of conduct disorder as well as a symptom of risky or problem gambling, according to new research findings from the University at Buffalo's Research Institute on Addictions (RIA).

24 Oct 2009